Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Interventional Cardiology in Cancer Patients
Author(s): Dan Lenihan, Joe Carver, Miguel Nobre Menezes Start date: Mar 13, 2025
Join Dr Miguel N. Menezes, (Santa Maria University Hospital, PT), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) as they explore the vital role of cardio-oncology in managing cardiovascular complications that arise from cancer treatments.The experts will discuss innovative interventional strategies to optimise heart health in cancer… View more

CV Disease in Special Populations
ACC 25 Late-Breaking Discussion: The API-Cat Study
Author(s): Harriette Van Spall , Isabelle Mahé Added: 10 months ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the… View more

Anticoagulation

Vascular Disease and Surgery
Looking Beyond the Usual Suspects: A Rare Case of Stiff Left Atrial Syndrome after Radiotherapy for Breast Cancer
Author(s): Sukriti Banthiya , Medhat Chowdhury , Harshil Patel , et al Added: 2 years ago

CV Disease in Special Populations
ESC 23: The ONCO DVT Study
Author(s): Yugo Yamashita Added: 2 years ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502). The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients… View more

Anticoagulation

Vascular Disease and Surgery
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 1 year ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
Nicola Maurea
Job title: Director of Division of Cardiology
Prof Nicola Maurea graduated in medicine where he specialised in Cardiology and Internal Medicine; he has obtained all degrees with full marks and honors from the University of Naples Federico II. He is the Director of Division of Cardiology at the National Cancer Institute, Pascale Foundation, Naples. He is a distinguished expert in the field of the American College of Cardiology and he is the… View more
Dr Michael D Stubblefield is Medical Director for Cancer Rehabilitation at Kessler Institute for Rehabilitation, National Medical Director for Select Medical’s ReVital Cancer Rehabilitation Program and National Medical Director for Complex Medical Rehabilitation for Select Medical’s Inpatient Rehabilitation Hospital Division. He is President of the International Cancer Rehabilitation Foundation… View more
Danielle Cuthbert
Job title: Medical Oncologist
Dr. Danielle (Dani) Cuthbert is a Medical Oncologist at St. Michael’s Hospital and Assistant Professor at the University of Toronto. She completed medical school and internal medicine residency at Northwestern University Feinberg School of Medicine in Chicago. She then returned home to Toronto in 2020 for medical oncology residency followed by a clinical fellowship in breast oncology at Princess… View more
Teresa Taft Levitch is a strategic healthcare communicator, writer, and patient advocate whose work focuses on cancer rehabilitation, survivorship, and cardiovascular health. She has developed patient-centered content and campaigns for organisations including the CDC Foundation, AstraZeneca, Memorial Sloan Kettering Cancer Center, the American Heart Association, and the Cancer Survivorship &… View more